Published in Law and Health Weekly, August 26th, 2006
Different migration characteristics among botulinum toxin type A formulations may result in different tolerability profiles, according to the researchers.
"Our study reinforces the important fact that no two botulinum toxins are alike. Each behaves differently, physiologically and clinically, and each has a unique structure, formulation,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly